Literature DB >> 15858003

Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E.

Bone S F Tang1, Kwok-Hung Chan, Vincent C C Cheng, Patrick C Y Woo, Susanna K P Lau, Clarence C K Lam, Tsun-Leung Chan, Alan K L Wu, Ivan F N Hung, Suet-Yi Leung, Kwok-Yung Yuen.   

Abstract

The pathogenesis of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) at the cellular level is unclear. No human cell line was previously known to be susceptible to both SARS-CoV and other human coronaviruses. Huh7 cells were found to be susceptible to both SARS-CoV, associated with SARS, and human coronavirus 229E (HCoV-229E), usually associated with the common cold. Highly lytic and productive rates of infections within 48 h of inoculation were reproducible with both viruses. The early transcriptional profiles of host cell response to both types of infection at 2 and 4 h postinoculation were determined by using the Affymetrix HG-U133A microarray (about 22,000 genes). Much more perturbation of cellular gene transcription was observed after infection by SARS-CoV than after infection by HCoV-229E. Besides the upregulation of genes associated with apoptosis, which was exactly opposite to the previously reported effect of SARS-CoV in a colonic carcinoma cell line, genes related to inflammation, stress response, and procoagulation were also upregulated. These findings were confirmed by semiquantitative reverse transcription-PCR, reverse transcription-quantitative PCR for mRNA of genes, and immunoassays for some encoded proteins. These transcriptomal changes are compatible with the histological changes of pulmonary vasculitis and microvascular thrombosis in addition to the diffuse alveolar damage involving the pneumocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858003      PMCID: PMC1091719          DOI: 10.1128/JVI.79.10.6180-6193.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.

Authors:  Siu Tsan Yuen; Tsun Leung Chan; Judy W C Ho; Annie S Y Chan; Lap Ping Chung; Polly W Y Lam; Chun Wah Tse; Andrew H Wyllie; Suet Yi Leung
Journal:  Oncogene       Date:  2002-10-24       Impact factor: 9.867

2.  Reovirus-induced alterations in gene expression related to cell cycle regulation.

Authors:  George J Poggioli; Roberta L DeBiasi; Ryan Bickel; Robert Jotte; Aaron Spalding; Gary L Johnson; Kenneth L Tyler
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

4.  A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection.

Authors:  A A Bashirova; T B Geijtenbeek; G C van Duijnhoven; S J van Vliet; J B Eilering; M P Martin; L Wu; T D Martin; N Viebig; P A Knolle; V N KewalRamani; Y van Kooyk; M Carrington
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

5.  An outbreak of coronavirus OC43 respiratory infection in Normandy, France.

Authors:  Astrid Vabret; Thomas Mourez; Stéphanie Gouarin; Joëlle Petitjean; François Freymuth
Journal:  Clin Infect Dis       Date:  2003-04-04       Impact factor: 9.079

6.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

7.  Rhinovirus and coronavirus infection-associated hospitalizations among older adults.

Authors:  Ann R Falsey; Edward E Walsh; Frederick G Hayden
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

8.  Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.

Authors:  Patrick C Y Woo; Susanna K P Lau; Hoi-wah Tsoi; Kwok-hung Chan; Beatrice H L Wong; Xiao-yan Che; Victoria K P Tam; Sidney C F Tam; Vincent C C Cheng; Ivan F N Hung; Samson S Y Wong; Bo-jian Zheng; Yi Guan; Kwok-yung Yuen
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

9.  Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS).

Authors:  W H Seto; D Tsang; R W H Yung; T Y Ching; T K Ng; M Ho; L M Ho; J S M Peiris
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

10.  Development of a standard treatment protocol for severe acute respiratory syndrome.

Authors:  Loletta K-Y So; Arthur C W Lau; Loretta Y C Yam; Thomas M T Cheung; Edwin Poon; Raymond W H Yung; K Y Yuen
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

View more
  57 in total

1.  Titration of human coronaviruses, HcoV-229E and HCoV-OC43, by an indirect immunoperoxidase assay.

Authors:  Francine Lambert; Hélène Jacomy; Gabriel Marceau; Pierre J Talbot
Journal:  Methods Mol Biol       Date:  2008

2.  Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus.

Authors:  Tracey Baas; Anjeanette Roberts; Thomas H Teal; Leatrice Vogel; Jun Chen; Terrence M Tumpey; Michael G Katze; Kanta Subbarao
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

3.  A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.

Authors:  Krishnamurthy Malathi; Jayashree M Paranjape; Elena Bulanova; Minsub Shim; Jeanna M Guenther-Johnson; Pieter W Faber; Thomas E Eling; Bryan R G Williams; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 4.  Systems biology unravels interferon responses to respiratory virus infections.

Authors:  Andrea L Kroeker; Kevin M Coombs
Journal:  World J Biol Chem       Date:  2014-02-26

5.  Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19.

Authors:  Ahmed Abdulwahid Salman; Mohammed Hussein Waheed; Akeel Abd Ali-Abdulsahib; Zeenah Weheed Atwan
Journal:  Biomed Rep       Date:  2021-03-09

6.  Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication.

Authors:  Liang Zhang; Zhi-Ping Zhang; Xian-En Zhang; Fu-Sen Lin; Feng Ge
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

7.  Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC.

Authors:  Kam-Leung Siu; Kit-San Yuen; Carlos Castaño-Rodriguez; Zi-Wei Ye; Man-Lung Yeung; Sin-Yee Fung; Shuofeng Yuan; Chi-Ping Chan; Kwok-Yung Yuen; Luis Enjuanes; Dong-Yan Jin
Journal:  FASEB J       Date:  2019-04-29       Impact factor: 5.191

8.  Unraveling the complexities of the interferon response during SARS-CoV infection.

Authors:  Anna de Lang; Tracey Baas; Saskia L Smits; Michael G Katze; Albert Dme Osterhaus; Bart L Haagmans
Journal:  Future Virol       Date:  2009-01-01       Impact factor: 1.831

Review 9.  SARS coronavirus accessory proteins.

Authors:  Krishna Narayanan; Cheng Huang; Shinji Makino
Journal:  Virus Res       Date:  2007-11-28       Impact factor: 3.303

10.  Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Tomoki Yoshikawa; Terence E Hill; Naoko Yoshikawa; Vsevolod L Popov; Cristi L Galindo; Harold R Garner; C J Peters; Chien-Te Kent Tseng
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.